Minerva Neurosciences Inc (NASDAQ:NERV)
| 2.91 Delayed Data As of Feb 03 |  +0.39 / +15.48%Today’s Change | 1.26 Today|||52-Week Range 15.27 | +83.02% Year-to-Date |
Latest NERV News | Press Releases
No recent news for Minerva Neurosciences Inc.
Today’s Trading
| Previous close | 2.52 |
| Today’s open | 2.66 |
| Day’s range | 2.66 - 3.10 |
| Volume | 3,872 |
| Average volume (3 months) | 269,144 |
| Market cap | $10.4M |
Data as of 3:57pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -2,557.38% |
| Earnings growth (this year) | +58.34% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.31 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Kyto Technology and ... | 0.00 | 0.00% |
| ARDSAridis Pharmaceutica... | 0.00 | 0.00% |
| TRVNTrevena Inc | 0.00 | 0.00% |
| CYCCCyclacel Pharmaceuti... | 0.00 | 0.00% |
Data as of 3:59pm ET, 02/03/2023
Financials
| Next reporting date | March 13, 2023 |
| EPS forecast (this quarter) | -$1.01 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$49.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Waltham, Massachusetts |
Forecasts
